686 related articles for article (PubMed ID: 31755111)
21. Acute Treatment Patterns, Migraine Burden, and Healthcare Resource Use in People With Migraine: Results From the OVERCOME (EU) Observational Study.
Evers S; Dell'Agnello G; Novick D; Gonderten HS; Panni T; Pascual J
Pain Ther; 2024 Jun; 13(3):589-607. PubMed ID: 38625512
[TBL] [Abstract][Full Text] [Related]
22. The effectiveness of agomelatine on headache severity and frequency in episodic migraine without aura; a parallel randomized controlled trial study.
Farzin K; Kheiltash A; Tafakhori A; Nakhjiri NE; Sabet MS; Nayeri ND
BMC Neurol; 2024 Jan; 24(1):2. PubMed ID: 38166859
[TBL] [Abstract][Full Text] [Related]
23. Interrelation of chronic tension-type headache with and without medication overuse and migraine in the general population: the Akershus study of chronic headache.
Aaseth K; Grande RB; Lundqvist C; Russell MB
Cephalalgia; 2009 Mar; 29(3):331-7. PubMed ID: 19220315
[TBL] [Abstract][Full Text] [Related]
24. A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability.
Lipton RB; Manack Adams A; Buse DC; Fanning KM; Reed ML
Headache; 2016 Sep; 56(8):1280-9. PubMed ID: 27349336
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics and overuse patterns of medication overuse headache: Retrospective case-series study.
Kluonaitis K; Petrauskiene E; Ryliskiene K
Clin Neurol Neurosurg; 2017 Dec; 163():124-127. PubMed ID: 29101861
[TBL] [Abstract][Full Text] [Related]
26. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
[TBL] [Abstract][Full Text] [Related]
27. Does Mindfulness-Based Cognitive Therapy for Migraine Reduce Migraine-Related Disability in People with Episodic and Chronic Migraine? A Phase 2b Pilot Randomized Clinical Trial.
Seng EK; Singer AB; Metts C; Grinberg AS; Patel ZS; Marzouk M; Rosenberg L; Day M; Minen MT; Lipton RB; Buse DC
Headache; 2019 Oct; 59(9):1448-1467. PubMed ID: 31557329
[TBL] [Abstract][Full Text] [Related]
28. Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
Lipton RB; Hutchinson S; Ailani J; Reed ML; Fanning KM; Manack Adams A; Buse DC
Headache; 2019 Nov; 59(10):1762-1772. PubMed ID: 31544244
[TBL] [Abstract][Full Text] [Related]
29. Predictors of treatment-response to caffeine combination products, acetaminophen, acetylsalicylic acid (aspirin), and nonsteroidal anti-inflammatory drugs in acute treatment of episodic migraine.
Ezzati A; Fanning KM; Reed ML; Lipton RB
Headache; 2023 Mar; 63(3):342-352. PubMed ID: 36748728
[TBL] [Abstract][Full Text] [Related]
30. Use of a pine bark extract and antioxidant vitamin combination product as therapy for migraine in patients refractory to pharmacologic medication.
Chayasirisobhon S
Headache; 2006 May; 46(5):788-93. PubMed ID: 16643582
[TBL] [Abstract][Full Text] [Related]
31. Medication-Overuse Headache: Protocols and Outcomes in 149 Consecutive Patients in a Tertiary Brazilian Headache Center.
Krymchantowski AV; Tepper SJ; Jevoux C; Valença M
Headache; 2017 Jan; 57(1):87-96. PubMed ID: 27861826
[TBL] [Abstract][Full Text] [Related]
32. Patients With Migraine Have Substantial Reductions in Measures of Visual Quality of Life.
Hanson LL; Ahmed Z; Katz BJ; Warner JEA; Crum AV; Zhang Y; Zhang Y; Baggaley S; Pippitt K; Cortez MM; Digre KB
Headache; 2018 Jul; 58(7):1007-1013. PubMed ID: 29877580
[TBL] [Abstract][Full Text] [Related]
33. Non-aura visual disturbance with high visual aura rating scale scores has stronger association with migraine chronification than typical aura.
Tsao YC; Wang YF; Fuh JL; Chen WT; Lai KL; Liu HY; Wang SJ; Chen SP
Cephalalgia; 2022 Dec; 42(14):1487-1497. PubMed ID: 36068697
[TBL] [Abstract][Full Text] [Related]
34. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
Lipton RB; Munjal S; Buse DC; Fanning KM; Bennett A; Reed ML
Headache; 2016 Nov; 56(10):1635-1648. PubMed ID: 27731896
[TBL] [Abstract][Full Text] [Related]
35. Depressive symptoms and insecure attachment as predictors of disability in a clinical population of patients with episodic and chronic migraine.
Rossi P; Di Lorenzo G; Malpezzi MG; Di Lorenzo C; Cesarino F; Faroni J; Siracusano A; Troisi A
Headache; 2005 May; 45(5):561-70. PubMed ID: 15953275
[TBL] [Abstract][Full Text] [Related]
36. Migraine changes with age: IMPACT on migraine classification.
Kelman L
Headache; 2006; 46(7):1161-71. PubMed ID: 16866720
[TBL] [Abstract][Full Text] [Related]
37. Chronic versus episodic migraine: The 15-day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency.
Ishii R; Schwedt TJ; Dumkrieger G; Lalvani N; Craven A; Goadsby PJ; Lipton RB; Olesen J; Silberstein SD; Burish MJ; Dodick DW
Headache; 2021 Jul; 61(7):992-1003. PubMed ID: 34081791
[TBL] [Abstract][Full Text] [Related]
38. [Headache registry in Szeged: Experiences regarding to migraine patients].
Plander M; Tajti J; Vécsei L; Szok D
Ideggyogy Sz; 2023 May; 76(5-6):205-211. PubMed ID: 37294022
[TBL] [Abstract][Full Text] [Related]
39. MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention.
Belvís R; Irimia P; Pozo-Rosich P; González-Oria C; Cano A; Viguera J; Sánchez B; Molina F; Beltrán I; Oterino A; Cuadrado E; Gómez-Camello A; Alberte-Woodward M; Jurado C; Oms T; Ezpeleta D; de Terán JD; Morollón N; Latorre G; Torres-Ferrús M; Alpuente A; Lamas R; Toledano C; Leira R; Santos S; Del Río MS
J Headache Pain; 2021 Jul; 22(1):74. PubMed ID: 34273947
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
